ENDOCYTE INC·4

Sep 4, 4:00 PM ET

ENDOCYTE INC 4

4 · ENDOCYTE INC · Filed Sep 4, 2013

Insider Transaction Report

Form 4
Period: 2013-08-30
Ritter Allen R
VP of Manufacturing/CMC
Transactions
  • Sale

    Common Stock

    2013-08-30$14.36/sh6,000$86,16017,722 total
  • Exercise/Conversion

    Common Stock

    2013-08-30$2.10/sh+6,000$12,60023,722 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2013-08-306,00012,560 total
    Exercise: $2.10Exp: 2017-02-01Common Stock (6,000 underlying)
Footnotes (2)
  • [F1]This option is fully vested and immediately exercisable.
  • [F2]Represents the sale of 6,000 shares in multiple transactions, ranging in price from $14.26 to $14.45 per share, resulting in a weighted average sale price per share of $14.36. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range.

Documents

1 file
  • 4
    v354336_form4.xmlPrimary

    FORM 4